InvestorsHub Logo
Followers 0
Posts 1088
Boards Moderated 0
Alias Born 07/08/2010

Re: Chartman17 post# 28243

Friday, 10/01/2010 12:50:30 AM

Friday, October 01, 2010 12:50:30 AM

Post# of 59551
Class III devise via PMA route is where the FDA is taking this. A way too much attention has been given to PMA in the 10-K/A. (read it). Dean is starting to come clean and preparing shareholders for the long haul. If you thnk there has been a delay so far, you havn't seen anything yet.